Fritextsökning
Innehållstyper
-
Medivir CEO on upcoming study: ”It's about working together with others”
Medivir is a small company with a big task: to take its drug candidate, via extensive clinical studies, all the way to a patient group that currently lacks appr...
-
Setback for pharmaceutical companies in the Zantac case
A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.
-
Mångmiljonböter för diagnostikbolag – vilseledde marknaden
Magnasense, tidigare Aegirbio, ska betala 12 miljoner kronor i sanktionsavgift. Det slår Finansinspektionen fast, efter en granskning som visar att bolaget uppr...
-
The Future of Swedish & Danish Life Science 2026
-
One last chance to register for the premier metrology event in 2024
ZEISS QUALITY INNOVATION SUMMIT.
-
FHM ska leda expertlabb för ebola och okända virussjukdomar
Folkhälsomyndigheten har fått ansvar för att driva det europeiska referenslaboratoriet för smittsamma sjukdomar som ebola, marburg och rabies. Uppdraget omfatta...
-
The key to successful collaboration between industry and academia
Why is collaboration between industry and academia necessary in the life sciences sector? What obstacles exist, and what is the key to successful collaboration?
-
AI detects tumor disease – via voice recording
A short voice recording along with facial images – both analyzed with an AI algorithm – can make it possible to detect the rare tumour disease acromegaly and in...
-
Unmatched performance and flexibility in its class
The new ZEISS SPECTRUM family is equipped to be the ideal match from measuring small electronics up to larger housings.
-
Advancing Drug Discovery by Combining Complex In-Vitro Models with AI-Powered 3D/4D Image Analysis
Free webinar organized by ZEISS.
-
Revealing the secrets of a part
CT inspection in automation technology at Festo.
-
Several departures at the top at Nykode
Members of both the management and the board are leaving the Norwegian biotech company Nykode.
-
Inget statligt stöd för fetmaläkemedel – aktien för läkemedelsjättar pressas
Trump-administrationen slopar Bidens förslag om att om att inkludera fetmaläkemedel i sjukförsäkringen Medicare. Det innebär ett bakslag för Novo Nordisk och El...
-
Rise and Scantox cease conducting animal testing in Stockholm
Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...
-
En portion hållbarhet
Att navigera i hållbarhetslabyrinten är inte alltid lätt, vilken bransch det än gäller. Men för livsmedels- och dryckesindustrin är utmaningarna extra stora. Ef...
-
Enhance your expertise with your measuring software
Discover the training options in our ZEISS Metrology Portal.
-
FDA vill ersätta djurförsök med AI – ”Paradigmskifte”
Krav på djurförsök vid läkemedelsutveckling ska fasas ut och ersättas med AI, meddelade FDA på torsdagen. Beskedet möts av skepsis från den nationella föreninge...
-
ZEISS Microscope has been Optimized for Capturing Subcellular Structures and their Dynamics
Live imaging with uniform super-resolution in all spatial dimensions.
-
Webinar: Automate your processes
Free ZEISS webinar on January 30th, 2025.
-
Spatial Biology Studies in Lung Tissue using Spectral Microscopy
Spectral imaging with the ZEISS LSM 980 laser scanning confocal enables more complex studies of cell-cell interactions and locations in immunology research.
-
Obesity-drug pioneers win Lasker Award
This year’s Lasker Prize in Clinical Research has been awarded to three researchers for their discoveries in GLP-1-based drugs that, according to the jury, “hav...
-
Stockholm and Uppsala jointly form a life science cluster
Stockholm and Uppsala are strengthening cooperation in medical research and biotech.
-
The dock that “thinks” for itself
The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...
-
Bioscience – Groundbreaking Research & Diagnostics: Gothenburg 2026